Skip to main content
Premium Trial:

Request an Annual Quote

Time to Polish Those Resumes in Foster City

Yesterday's news that Invitrogen is buying Applied Biosystems for $6.7 billion stirred tremendous interest from the community. Our sister website GenomeWeb Daily News reports that "the deal would be the largest in the life sciences tools market since Thermo Electron bought Fisher Scientific for $10.6 billion in 2006." Invitrogen CEO Greg Lucier will head up the whole company, and current Applera CEO Tony White will be a consultant for five years once the deal is approved.

Over at Biofind's rumor mill, a post wonders "how long it will be before Invitrogen starts handing ABI people pink slips."

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.